NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Lucira Health Inc (NASDAQ: LHDX)
LHDX Technical Analysis
5
As on 5th May 2023 LHDX STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.63 & Strong Sell for SHORT-TERM with Stoploss of 6.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LHDXSTOCK Price
Open | 0.03 | Change | Price | % |
High | 0.04 | 1 Day | -0.01 | -25.00 |
Low | 0.03 | 1 Week | -0.02 | -40.00 |
Close | 0.03 | 1 Month | -0.18 | -85.71 |
Volume | 90481 | 1 Year | -7.03 | -99.58 |
52 Week High 8.94 | 52 Week Low 0.03 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
GNLN | 0.01 | 0.00% |
CNEY | 0.19 | 18.75% |
DGLY | 0.05 | 66.67% |
NVDA | 117.06 | 3.10% |
AGMH | 0.09 | 12.50% |
LCID | 2.25 | -3.43% |
GOOGL | 151.38 | -7.26% |
LMDX | 0.02 | 0.00% |
AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
LHDX Daily Charts |
LHDX Intraday Charts |
Whats New @ Bazaartrend |
LHDX Free Analysis |
|
LHDX Important Levels Intraday
RESISTANCE | 0.05 |
RESISTANCE | 0.04 |
RESISTANCE | 0.04 |
RESISTANCE | 0.04 |
SUPPORT | 0.02 |
SUPPORT | 0.02 |
SUPPORT | 0.02 |
SUPPORT | 0.01 |
LHDX Forecast May 2025
4th UP Forecast | 9.45 |
3rd UP Forecast | 6.43 |
2nd UP Forecast | 4.56 |
1st UP Forecast | 2.7 |
1st DOWN Forecast | -2.64 |
2nd DOWN Forecast | -4.5 |
3rd DOWN Forecast | -6.37 |
4th DOWN Forecast | -9.39 |
LHDX Weekly Forecast
4th UP Forecast | 4.37 |
3rd UP Forecast | 2.98 |
2nd UP Forecast | 2.12 |
1st UP Forecast | 1.26 |
1st DOWN Forecast | -1.20 |
2nd DOWN Forecast | -2.06 |
3rd DOWN Forecast | -2.92 |
4th DOWN Forecast | -4.31 |
LHDX Forecast2025
4th UP Forecast | 18.55 |
3rd UP Forecast | 12.61 |
2nd UP Forecast | 8.94 |
1st UP Forecast | 5.27 |
1st DOWN Forecast | -5.21 |
2nd DOWN Forecast | -8.88 |
3rd DOWN Forecast | -12.55 |
4th DOWN Forecast | -18.49 |
Lucira Health Inc ( NASDAQ USA Symbol : LHDX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LHDX Other Details
Segment | EQ | |
Market Capital | 228322928.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
LHDX Address
![]() |
LHDX Latest News
LHDX Business Profile
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. Address: 1412 62nd Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service